Screener
Rhythm Pharmaceuticals, Inc. RYTM Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$49.3M-5.7% | -$55.64M-12.4% | -$47.51M-9.7% | -$52.9M-21.1% | -$46.63M-44.5% | ||
| $26.06M+64.1% | $23.1M+79.6% | $19.27M+82.5% | $18.81M+71.0% | $15.88M+53.3% | ||
| -$9.15M+60.7% | -$44.19M-9.5% | -$25.39M-34.7% | -$26.62M-5.6% | -$23.31M+19.8% | ||
| $14.01M-74.1% | $57.05M+130% | —— | -$246.35M-171% | $54.04M— | ||
| $6.91M+59.4% | $4.29M-7.1% | $5.4M+41.8% | $5.57M+67.0% | $4.33M+45.7% | ||
| -$1.17M— | -$5.4M-117% | —— | $189.3M+7,496% | —— | ||
| $3.48M-88.2% | $7.92M-53.3% | $0-100% | -$83.36M+27.0% | $29.55M-72.7% |
FAQ
- How much cash does Rhythm Pharmaceuticals, Inc. generate?
- Rhythm Pharmaceuticals, Inc. (RYTM) generated -$105.3M in operating cash flow over the trailing twelve months.
- Where does Rhythm Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Rhythm Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
